May 6 (Reuters) - Oncternal Therapeutics Inc :
* ONCTERNAL PROVIDES BUSINESS UPDATE AND ANNOUNCES FIRST QUARTER 2021 FINANCIAL RESULTS
* Q1 LOSS PER SHARE $0.12
* ONCTERNAL THERAPEUTICS - BELIEVE CURRENT CASH AND CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND OPERATIONS INTO 2023
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* ONCTERNAL PROVIDES BUSINESS UPDATE AND ANNOUNCES FIRST QUARTER 2021 FINANCIAL RESULTS
* Q1 LOSS PER SHARE $0.12
* ONCTERNAL THERAPEUTICS - BELIEVE CURRENT CASH AND CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND OPERATIONS INTO 2023
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)